Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES AJANTA PHARMA DIVIS LABORATORIES/
AJANTA PHARMA
 
P/E (TTM) x 66.0 38.3 172.2% View Chart
P/BV x 7.1 8.3 85.9% View Chart
Dividend Yield % 0.9 0.3 279.1%  

Financials

 DIVIS LABORATORIES   AJANTA PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
AJANTA PHARMA
Mar-23
DIVIS LABORATORIES/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,6411,426 325.5%   
Low Rs2,7301,062 257.0%   
Sales per share (Unadj.) Rs292.6297.2 98.4%  
Earnings per share (Unadj.) Rs68.746.7 147.1%  
Cash flow per share (Unadj.) Rs81.657.1 143.0%  
Dividends per share (Unadj.) Rs30.007.00 428.6%  
Avg Dividend yield %0.80.6 144.7%  
Book value per share (Unadj.) Rs480.9269.1 178.7%  
Shares outstanding (eoy) m265.47125.91 210.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.64.2 301.0%   
Avg P/E ratio x53.726.6 201.4%  
P/CF ratio (eoy) x45.221.8 207.2%  
Price / Book Value ratio x7.74.6 165.7%  
Dividend payout %43.715.0 291.4%   
Avg Mkt Cap Rs m978,378156,638 624.6%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7507,851 124.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67537,426 207.5%  
Other income Rs m3,447986 349.4%   
Total revenues Rs m81,12238,413 211.2%   
Gross profit Rs m23,6917,833 302.5%  
Depreciation Rs m3,4321,308 262.4%   
Interest Rs m2058 33.6%   
Profit before tax Rs m23,6867,453 317.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,4531,573 346.7%   
Profit after tax Rs m18,2345,880 310.1%  
Gross profit margin %30.520.9 145.7%  
Effective tax rate %23.021.1 109.1%   
Net profit margin %23.515.7 149.4%  
BALANCE SHEET DATA
Current assets Rs m97,43728,252 344.9%   
Current liabilities Rs m15,33111,393 134.6%   
Net working cap to sales %105.745.0 234.7%  
Current ratio x6.42.5 256.3%  
Inventory Days Days866 12.7%  
Debtors Days Days84210 8,172.0%  
Net fixed assets Rs m51,12818,707 273.3%   
Share capital Rs m531253 210.1%   
"Free" reserves Rs m127,14033,624 378.1%   
Net worth Rs m127,67133,877 376.9%   
Long term debt Rs m013 0.0%   
Total assets Rs m148,56547,047 315.8%  
Interest coverage x1,209.5128.6 940.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.8 65.7%   
Return on assets %12.312.6 97.3%  
Return on equity %14.317.4 82.3%  
Return on capital %18.622.2 83.8%  
Exports to sales %85.759.9 143.0%   
Imports to sales %19.811.5 172.6%   
Exports (fob) Rs m66,53722,420 296.8%   
Imports (cif) Rs m15,3784,293 358.2%   
Fx inflow Rs m66,53722,420 296.8%   
Fx outflow Rs m15,7154,293 366.0%   
Net fx Rs m50,82218,127 280.4%   
CASH FLOW
From Operations Rs m24,5977,918 310.7%  
From Investments Rs m-27,076-5,596 483.8%  
From Financial Activity Rs m-7,972-1,079 739.0%  
Net Cashflow Rs m-10,4511,243 -840.7%  

Share Holding

Indian Promoters % 51.9 66.2 78.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.7 25.8 142.5%  
FIIs % 14.9 9.1 163.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 33.8 142.3%  
Shareholders   354,482 54,351 652.2%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs AJANTA PHARMA Share Price Performance

Period Divis Laboratories AJANTA PHARMA S&P BSE HEALTHCARE
1-Day 2.14% 2.51% 1.18%
1-Month -2.15% 7.60% -0.75%
1-Year 22.51% 92.91% 61.82%
3-Year CAGR -1.38% 21.63% 18.16%
5-Year CAGR 15.77% 26.85% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.